Abstract

The drug company Eli Lilly and Co has agreed to a $29.4m (£18.2m; €22.3m) settlement with the US Securities and Exchange Commission for violation of the US Foreign Corrupt Practices...

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call